Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Zelira Therapeutics Limited
  6. News
  7. Summary
    ZLD   AU000000ZLD1

ZELIRA THERAPEUTICS LIMITED

(ZLD)
Delayed Quote. Delayed Australian Stock Exchange - 01/16 11:30:01 pm
0.031 AUD   -3.13%
01/12Argenica Therapeutics Appoints New Head of Clinical Development
MT
01/12ZELIRA THERAPEUTICS : 2021 Annual General Meeting Presentation
PU
01/11Zelira Therapeutics Secures R&D Tax Rebate; Shares Rise 3%
MT
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Zelira Therapeutics : Subsidiary Launches Acne Treatment Product Line in US; Shares Soar 13%

09/22/2021 | 10:07pm EST


ę MT Newswires 2021
All news about ZELIRA THERAPEUTICS LIMITED
01/12Argenica Therapeutics Appoints New Head of Clinical Development
MT
01/12ZELIRA THERAPEUTICS : 2021 Annual General Meeting Presentation
PU
01/11Zelira Therapeutics Secures R&D Tax Rebate; Shares Rise 3%
MT
01/10Zelira Therapeutics Receives Partial Payment for Technology License Fee
MT
2021Med Journal Publishes Results of Zelira Therapeutics' Medicinal Cannabis Product for Ch..
MT
2021Zelira Therapeutics Expands to New Zealand with New Distribution Deal
MT
2021Zelira Therapeutics Limited Expands into New Zealand Via Exclusive Distribution Agreeme..
CI
2021Zelira Therapeutics Secures Ethics Approval for Phase 2 Trial of Chronic Pain Drug; Sha..
MT
2021ZLD Supports Levins Chronic Pain Trial Ethics Approval
CI
2021ZELIRA THERAPEUTICS : Notification regarding unquoted securities - ZLD
PU
More news
Financials
Sales 2021 0,66  0,48  0,48 
Net income 2021 -8,55 M -6,16 M -6,16 M
Net cash 2021 4,42 M 3,19 M 3,19 M
P/E ratio 2021 -5,84x
Yield 2021 -
Capitalization 41,0 M 29,6 M 29,6 M
EV / Sales 2020 -
EV / Sales 2021 70 500 112x
Nbr of Employees -
Free-Float 72,4%
Chart ZELIRA THERAPEUTICS LIMITED
Duration : Period :
Zelira Therapeutics Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZELIRA THERAPEUTICS LIMITED
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Managers and Directors
Oludare Odumosu Chief Executive Officer, Director & MD
Osagie O. Imasogie Chairman
Harry Karelis Non-Executive Deputy Chairman
Lisa Gray Director
Jason William Peterson Non-Executive Director
Sector and Competitors